N-acetyltransferase 2 (Nat2) polymorphism in the sand rat Psammomys obesus

References

• Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P. 2003. Arylamine N-acetyltransferase 1 is highly expressed in breast cancer and conveys enhanced growth and resistance to etoposide in vitro. Mol Cancer Res 1:826–835.
   PubMed Web of Science ®Google Scholar
• Boukouvala S, Fakis G. 2005. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev 37:511–564.
   PubMed Web of Science ®Google Scholar
• Boukouvala S, Price N, Sim E. 2002. Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice. Pharmacogenetics 12:385–394.
   PubMedGoogle Scholar
• Bozaoglu K, Curran JE, Elliot KS, Walder KR, Dyer TD, Rainwater DL, Vandeberg JL, Comuzzie AG, Collier GR, Zimmet P, MacCluer JW, Jowett JB, Blangero J. 2006. Association of genetic variation within UBLS with phenotypes of metabolic syndrome. Hum Biol 78:147–159.
   PubMedGoogle Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Czernobilsky B, Ungar H, Adler JH. 1982. Spontaneous uterine neoplasm in the fat sand rat (Psammomys obesus). Lab Anim 16:285–289.
   PubMedGoogle Scholar
• Daly M, Daly S. 1973. On the feeding ecology of Psammonys obesus (Rodentia, Gerbillidae) in the Wadi Saoura, Algeria. Mammalia 37:546–561.
   Google Scholar
• Doll MA, Hein DW. 1995. Cloning, sequencing and expression of NATI and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics 5:247–251.
   PubMedGoogle Scholar
• Estrada-Rodgers L, Levy GN, Weber WW. 1998. Substrate selectivity of mouse N- acetyltransferases 1, 2, and 3 expressed in Cos-1 cells. Drug Metab Dispos 5:502–508.
   Google Scholar
• Fiala ES, Weisburger JH, Katayama S, Chandrasekaran V, Williams GM. 1981. The effect of disulfiram on the carcinogenicity of 3,2' dimethyl-4-aminobiphenyl in Syrian golden hamsters and rats. Carcinogenesis 2:965–969.
   PubMed Web of Science ®Google Scholar
• Glowinski IB, Weber WW. 1982. Biochemical characterization of genetically variant aromatic amine N-acetyltransferases in A/J and C57BL/6J mice. J Biol Chem 257:1431–1437.
   PubMed Web of Science ®Google Scholar
• Hein DW. 2002. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506:65–77.
   PubMedGoogle Scholar
• Hein DW, Bendaly J, Neale JR, Doll MA. 2008. Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat. Drug Metabol Dispos 36:2452–2459.
   PubMedGoogle Scholar
• Hein DW, Doll MA, Fretland Leff, MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. 2000. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidem Biomar 9:29–42.
   PubMed Web of Science ®Google Scholar
• Hein DW, Doll MA, Nerland DE, Fretland AJ. 2006. Tissue distribution of N-acetyltransferases 1 and 2 catalysing the N-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol Carcinogen 45:230–238.
   PubMed Web of Science ®Google Scholar
• Hein DW, Dull MA, Fretland AJ, Gray K, Detz AC, Feng Y, Jiang W, Rustan TD, Satran SL Wilkie TR, Sr. 1997. Rodents models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat Res 376:101–106.
   PubMedGoogle Scholar
• Hein DW, Rustan TD, Bucher KD, Martin WJ, Furman EJ. 1991. Acetylator phenotype-dependent and independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab Dispos 19:933–937.
   PubMed Web of Science ®Google Scholar
• Hein DW, Smolen TN, Fox RR, Weber WW. 1982. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. J Pharmacol Exp Ther 223:40–44.
   PubMed Web of Science ®Google Scholar
• Hein DW, Trinidad A, Yerokun T, Ferguson RJ, Kirlin WG, Weber  WW. 1988. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1 and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse. Drug Metab Dispos 16:341–347.
   PubMed Web of Science ®Google Scholar
• Jiang W, Feng Y, Hein DW. 1999. Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl. Toxicol Appl Pharm 156:187–194.
   PubMed Web of Science ®Google Scholar
• Kaiser N, Nesher R, Donath MY, Fraenkel M, Behar V, Magnan C, Ktorza A, Cerasie E, Leibowitz G. 2005. Psammomys obesus, a model for environment-gene interactions in type 2 diabetes. Diabetes 54:137–144.
   Google Scholar
• Martell KJ, Levy GN, Weber WW. 1992. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat1 and Nat2 gene products. Mol Pharmacol 42:265–272.
   PubMed Web of Science ®Google Scholar
• McQueen CA, Chau B, Erickson RP, Tjalkens RB, Philbert MA. 2003. The effects of genetic variation in N-acetyltransferases on 4-aminobiphenyl genotoxicity in mouse liver. Chem-Biol Interact 146:51–60.
   PubMedGoogle Scholar
• Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1–3.
   PubMed Web of Science ®Google Scholar
• Shafrir E, Ziv E, Kalman R. 2006. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: acomys cahirinus (Spiny mice) and psammomys obesus (desert gerbil). ILAR J 47:212–224.
   PubMed Web of Science ®Google Scholar
• Sharpless NE, Depinho RA. 2006. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 5:741–754.
   PubMed Web of Science ®Google Scholar
• Shirai T, Nakamura A, Fukushima S, Yamamoto A, Tada M, Ito N. 1990. Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2 - dimethyl-4-aminobiphenyl. Carcinogenesis 11:793–797.
   PubMedGoogle Scholar
• Sim E, Westwood I, Fullam E. 2007. Arylamine N-acetyltransferases. Expert Opin Drug Metab Toxicol 3:169–184.
   PubMed Web of Science ®Google Scholar
• Sinclair JC, Delgoda R, Noble MEM, Jarmin S, Goh NK, Sim E. 1998. Purification, characterization, and crystallization of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium. Protein Expres Purif 12:371–380.
   PubMedGoogle Scholar
• Stanley LA, Copp AJ, Pope J, Rolls S, Smelt V, Perry VH, Sim E. 1998. Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58:174–182.
   PubMedGoogle Scholar
• Sugamori KS, Wong S, Gaedigk A, Yu V, Abramovici H, Rosemahel R, Grant DM. 2003. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 64:170–179.
   PubMed Web of Science ®Google Scholar
• Ungar H, Adler JH. 1978. The histogenesis of hepatoma occurring spontaneously in a strain of sand rats (Psammomys obesus). Am J Pathol 90:399–410.
   PubMedGoogle Scholar
• Ungar H, Adler JH. 1982. Naturally occurring polypoid hyperplasia and papilloma in gallbladders of the fat sand rat (Psammomys obesus). Vet Pathol 19:230–238.
   PubMedGoogle Scholar
• Wakefield L, Cornish V, Long H, Griffiths WJ, Sim E. 2007. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism. Biochem Biophys Res Commun 21:556–560.
   Google Scholar
• Wakefield L, Cornish V, Long H, Kawamura A, Zhang X, Hein DW, Sim E. 2008a. Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system. Biomarkers 13:106–118.
   PubMed Web of Science ®Google Scholar
• Wakefield L, Robinson J, Long H, Ibbit JC, Cooke S, Hurst HC, Sim E. 2008b. Arylamine N-acetyltransferase 1 expression in breast cancer cell- lines: a potential marker in oestrogen positive tumours. Genes Chromosome Can 47:118–126.
   PubMed Web of Science ®Google Scholar
• Walraven AJ, Doll MA, Hein DW. 2006. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rats arylamine N-acetyltransferases 1 and 2. J Pharmacol Exp Ther 319:369–375.
   PubMed Web of Science ®Google Scholar
• Ward A, Summer MJ, Sim E. 1995. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E.coli and characterization of the potential role in folate metabolism. Biochem Pharmacol 49:1759–1767.
   PubMed Web of Science ®Google Scholar
• Weber WW, Hein DW. 1985. N-acetylation pharmacogenetics. Pharmacol Rev 37:25–79.
   PubMed Web of Science ®Google Scholar
• Westwood IM, Kawamura A, Fullam E, Russell AJ, Davies SG, Sim E. 2006. Structure and mechanism of arylamine N-acetyltransferases. Curr Top Med Chem 6:1641–1654.
   PubMed Web of Science ®Google Scholar
• Wilson C, Brown D, Najarian K, Hanley EN, Gruber HE. 2003. Computer aided vertebral visualization and analysis: a methodology using the sand rat, a small animal model of disc degeneration. BMC Musculoskelet Disord 4:1–10.
   PubMedGoogle Scholar
• Zhang X, Lambert JC, Doll MA, Walraven JM, Arteel GE, Hein DW. 2006. 4,4-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat. J Pharmacol Exp Ther 316:289–294.
   PubMed Web of Science ®Google Scholar